Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Director's Dealing 2023

May 31, 2023

3782_dirs_2023-05-31_e1f3b7bf-4dfb-4832-8cbd-38ff35cbaeae.html

Director's Dealing

Open in viewer

Opens in your device viewer

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade

Magnus Tolleshaug, Chief Commercial Officer in Vistin Pharma ASA, and a primary

insider, has on 31(st) of May 2023 purchased 15.000 shares in Vistin Pharma ASA

at an average price of NOK 24,01 per share. Following this purchase Magnus

Tolleshaug holds 35.000 shares in Vistin Pharma ASA.